SIMVASTATIN
SIMVASTATIN is one of 8,063 medications in the MedPlain dataset. Key details — Brand name: SIMVASTATIN; Generic name: SIMVASTATIN; Drug class: HMG-CoA Reductase Inhibitor [EPC].
| Brand name | SIMVASTATIN |
|---|---|
| Generic name | SIMVASTATIN |
| Drug class | HMG-CoA Reductase Inhibitor [EPC] |
| Manufacturer | NuCare Pharmaceuticals,Inc. |
| Used for | 1 INDICATIONS AND USAGE Simvastatin tablets USP are indicated: To reduce the risk of total mortality by reducing risk of coronary heart disease death, non-fatal myocardial infarction and stroke, and the need for coronary and non-coronary revascularization procedures in adults with established coronary heart disease, cerebrovascular disease, peripheral vascular disease, and/or diabetes, who are at high risk of coronary heart disease events. As an adjunct to diet to reduce low-density lipoprotein cholesterol (LDL-C): In adults with primary hyperlipidemia. In adults and pediatric patients aged 10 years and older with heterozygous familial hypercholesterolemia (HeFH). As an adjunct to other LDL- |
| Dosage | 2 DOSAGE AND ADMINISTRATION Important Dosage and Administration Information : ( 1 ) Take simvastatin tablets USP orally once daily in the evening. Maximum recommended dosage is simvastatin tablets USP 40 mg once daily. simvastatin tablets USP 80 mg daily dosage is restricted to patients who have been taking simvastatin tablets USP 80 mg daily chronically (e.g., for 12 months or more) without evidence of muscle toxicity. For patients that require a high-intensity statin or are unable to achieve t |
| Active ingredient(s) | SIMVASTATIN |
| Route | ORAL |
| Official label | https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=06703194-b41a-2bbe-e063-6394a90ac41f |